Gritstone bio will participate in Upcoming Investor Conferences | Aici


Gritstone bio

EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will participate following investor conferences.

B. Riley Securities’ 3rd Annual Oncology Conference (Fire Talk)
Date and time: Thursday, January 19, 2023 at 12:30pm ET
Presenter: Andrew Allen, MD, Ph.D., Co-founder, President, and Chief Executive Officer

2023 BIO CEO and Investor Conference (Panel)
Panel Title: Prioritizing CRO Decommissioning in a Time of Rising Energy Rates, a Time of Tight Financing
Date and time: Monday, February 6, 2023 at 2:00pm ET
Presenter: Celia Economides, Chief Financial Officer

SVB Securities Global Biopharma Conference (Fire Talk)
Date and time: Thursday, February 16, 2023 at 1:40pm ET
Presenter: Andrew Allen, MD, Ph.D., Co-founder, President, and Chief Executive Officer

A live webcast and/or archived replay will be available via https://ir.gritstonebio.com/investors/events. Archived replays will be accessible for at least 30 days following the corresponding event.

About Gritstone bio
Gritstone is working to create the world’s most powerful vaccines. We are using our new vectors and payloads to train multiple arms of the immune system to attack targets in serious diseases and have programs against viruses and solid tumors. Independently and with our partners, we develop a portfolio of product candidates with the goal of improving patient outcomes and eradicating disease. www.gritstonebio.com

Gritstone contacts
Investors:
George E. MacDougall
Director, Investor Relations and Corporate Communications
Gritstone Bio, Inc.
ir@gritstone.com

Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *